LYRM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.422800E-01
Normal-vs-Stage2
1.218420E-01
Normal-vs-Stage3
5.820100E-02
Normal-vs-Stage4
9.001000E-01
Stage1-vs-Stage2
2.414000E-01
Stage1-vs-Stage3
2.580600E-01
Stage1-vs-Stage4
5.547600E-01
Stage2-vs-Stage3
4.103000E-01
Stage2-vs-Stage4
8.977600E-02
Stage3-vs-Stage4
2.040400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.137600E-01
Normal-vs-AfricanAmerican
3.897800E-01
Normal-vs-Asian
6.607600E-02
Caucasian-vs-AfricanAmerican
6.723400E-01
Caucasian-vs-Asian
1.515750E-01
AfricanAmerican-vs-Asian
1.385990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.519600E-01
Normal-vs-Female
3.447000E-01
Male-vs-Female
2.761400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.415800E-01
Normal-vs-Age(41-60Yrs)
3.813800E-01
Normal-vs-Age(61-80Yrs)
2.719000E-01
Normal-vs-Age(81-100Yrs)
1.749390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.521800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.888200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.795200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.407200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.070000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.869200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.068000E-02
Normal-vs-Daily Drinker
1.035670E-02
Normal-vs-Weekly Drinker
4.930800E-01
Normal-vs-Occasional Drinker
7.352800E-01
Normal-vs-Social Drinker
3.457000E-01
Non Drinker-vs-Daily Drinker
5.322000E-01
Non Drinker-vs-Weekly Drinker
2.125600E-01
Non Drinker-vs-Occasional Drinker
1.147790E-01
Non Drinker-vs-Social Drinker
6.765800E-02
Daily Drinker-vs-Weekly Drinker
1.262200E-01
Daily Drinker-vs-Occasional Drinker
6.812100E-02
Daily Drinker-vs-Social Drinker
3.201700E-02
Weekly Drinker-vs-Occasional Drinker
7.077600E-01
Weekly Drinker-vs-Social Drinker
9.836600E-01
Occasional Drinker-vs-Social Drinker
6.483400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.999600E-01
Normal-vs-Grade 2
9.588200E-01
Normal-vs-Grade 3
9.664600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.005400E-01
Grade 1-vs-Grade 3
1.026170E-01
Grade 1-vs-Grade 4
5.999600E-01
Grade 2-vs-Grade 3
8.818200E-01
Grade 2-vs-Grade 4
9.588200E-01
Grade 3-vs-Grade 4
9.664600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.756210E-01
Normal-vs-NonDiabetic
2.382200E-01
Diabetic-vs-NonDiabetic
2.811400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.935000E-03
Normal-vs-NoPancreatitis
2.712400E-01
Pancreatitis-vs-NoPancreatitis
1.607530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.317200E-01
Normal-vs-N1
1.343220E-01
N0-vs-N1
1.963420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.919210E-01
Normal-vs-TP53-NonMutant
8.381600E-01
TP53-Mutant-vs-TP53-NonMutant
9.444800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
